Martindale Pharma Appoints AAH, Sangers and TPS Healthcare as Wholesaler Partners for Distribution of Hospital Products

Published: Apr 30, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Brentwood April 30 2013: Martindale Pharma, a leading international speciality pharmaceuticals company, today announced a change to distribution of its product portfolio to UK hospitals with the appointment of AAH, Sangers and TPS Healthcare as wholesale distributors.

With effect from 6th May 2013, Martindale Pharma’s products will be supplied to NHS and private hospitals via a reduced wholesaler model under which there will only be one or two wholesalers supplying Martindale Pharma products to hospitals. The chosen partners are:

England AAH

Wales AAH

Northern Ireland Sangers and AAH

Scotland TPS Healthcare and AAH

Richard de Souza, Chief Executive Officer of Martindale Pharma, said:

“We are very proud of our position as a major supplier of essential medicines to NHS and private hospitals. We are also conscious of the pressure to improve efficiencies and reduce costs in the NHS. We believe that working closely with AAH, Sangers and TPS Healthcare will help Martindale Pharma to continue to improve product supply and customer service to our hospital customers.”

Commercial terms of these agreements were not disclosed.

From 6th May 2013, hospitals will no longer be able to order Martindale Pharma products from wholesalers other than those listed above.

For further information on the change in hospital distribution of Martindale Pharma products please contact:

General inquires - Customer Services – 0800 137 627

NHS Contract related inquires - Vikki Howard Commercial Manager - Hospital Speciality Products - +44 7891 785953

About Martindale Pharma®

After starting out as a London chemist store owned by William Martindale, Martindale Pharma has remained in business for more than a century and is now firmly established as a leading supplier to the UK’s NHS and exports its products to a number of other major pharmaceutical markets.

In May 2010 AAC Capital bought Martindale Pharma from Cardinal Health. AAC Capital continues to develop the business and pursue growth opportunities.

Martindale Pharma manufacture the majority of their products at their own facilities in the UK, in total producing and packing c.50 million doses a year in a range of formats including sterile ampoules/vials, oral solutions, pre-filled syringes, suppositories and ophthalmics.

Martindale Pharma’s key business segments are:

• Specials

• Critical Care

• Ophthalmics

• Hospital Specialty Products

• Addiction

For further information visit

Media contacts:

Martindale Pharma

Michael Clark

Tel: +44 (0) 1277 235300


Mary Clark / Amber Bielecka / Hollie Vile

Tel : +44 (0) 207 920 2361

Help employers find you! Check out all the jobs and post your resume.

Back to news